Therapeutic strategies to correct malfunction of CFTR.

Abstract excerpt

Cystic fibrosis (CF) is a systemic autosomal recessive inherited disorder that results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Although the gene was cloned 11 years ago, there still is no definitive treatment to correct the functional deficit. Current treatment strategies focus on pancreatic enzyme replacement and control of pulmonary inflammation and infection. This...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clinical Trials, Phase I as Topic
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Transmembrane Conductance Regulator